The biochemist introduced the first heel-prick tests for newborn babies in Spain, protecting infants from life-changing ...

A Seminole mom is fighting for her son's health after a rare disorder left him dependent on a strict medical diet. But now, ...

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data.

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and possible regeneration.

After hours: February 7 at 6:39:50 PM EST Loading Chart for BMRN ...

NEW YORK — MRC Holland said on Thursday that its blood-based assay for Temple, Kagami-Ogata, and Russell-Silver syndromes has received certification under Europe's In Vitro Diagnostic Regulation (IVDR ...